Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Response to the letter entitled “COPD-and-smoking-induced ‘down regulation’ of CO2-related vasoconstriction in the brain during CPAP for sleep apnea may paradoxically reduce risk of cardiovascular events”

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Jaster JH. COPD-and-smoking-induced ‘down regulation’ of CO2-related vasoconstriction in the brain during CPAP for sleep apnea may paradoxically reduce risk of cardiovascular events. https://doi.org/10.1007/s11325-020-02027-y

  2. 2.

    Myllylä M, Hammais A, Stepanov M, Anttalainen U, Saaresranta T, Laitinen T (2019) Nonfatal and fatal cardiovascular disease events in CPAP compliant obstructive sleep apnea patients. Sleep Breath 23:1209–1217

  3. 3.

    Brandon TH, Vidrine JI, Litvin EB (2007) Relapse and relapse prevention. Annu Rev Clin Psychol 3:257–284

Download references

Author information

Correspondence to Minna Myllylä.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Myllylä, M., Hammais, A., Stepanov, M. et al. Response to the letter entitled “COPD-and-smoking-induced ‘down regulation’ of CO2-related vasoconstriction in the brain during CPAP for sleep apnea may paradoxically reduce risk of cardiovascular events”. Sleep Breath (2020). https://doi.org/10.1007/s11325-020-02028-x

Download citation